Target intelligence / Profile preview

Bordetella pertussis Filamentous Haemagglutinin (FHA)

Target
FHA
Molecular classification
Adhesin, Protein
01

Overview

Filamentous haemagglutinin (FHA) is a large, rod-shaped protein produced by Bordetella pertussis, the bacterium responsible for whooping cough. FHA is both surface-associated and secreted, functioning primarily as an adhesin that mediates bacterial attachment to host cells. It is essential for colonization of the respiratory tract and plays a critical role in pathogenesis. FHA also contributes to biofilm formation and modulates immune responses, inhibiting antigen-dependent CD4+ T cell proliferation, inducing apoptosis in monocytes/macrophages, and downregulating IL-12 production through an IL-10-dependent mechanism. FHA is a key component of acellular pertussis vaccines due to its ability to elicit strong protective antibody responses.

Other names
fhaB gene productFHA adhesin
02

Mechanism of action

Antibody-mediated neutralization of FHA, preventing bacterial adhesion and colonization. Modulation of immune response.

03

Biological functions

AdhesionImmune modulationBiofilm formationColonization
04

Disease associations

InfectionWhooping cough (Pertussis)
05

Interacting drugs

Acellular pertussis vaccine components

Beyond the preview

Go deeper on Bordetella pertussis Filamentous Haemagglutinin (FHA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bordetella pertussis Filamentous Haemagglutinin (FHA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call